SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-036778
Filing Date
2024-03-20
Accepted
2024-03-20 17:20:07
Documents
14
Period of Report
2024-03-20
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm249395d1_8k.htm   iXBRL 8-K 25150
2 EXHIBIT 99.1 tm249395d1_ex99-1.htm EX-99.1 28063
  Complete submission text file 0001104659-24-036778.txt   231181

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mnk-20240320.xsd EX-101.SCH 3024
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnk-20240320_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnk-20240320_pre.xml EX-101.PRE 22366
17 EXTRACTED XBRL INSTANCE DOCUMENT tm249395d1_8k_htm.xml XML 3489
Mailing Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15
Business Address COLLEGE BUSINESS & TECHNOLOGY PARK CRUISERATH, BLANCHARDSTOWN DUBLIN 15 L2 D15 353 1 6960000
Mallinckrodt plc (Filer) CIK: 0001567892 (see all company filings)

IRS No.: 981088325 | Fiscal Year End: 1229
Type: 8-K | Act: 34 | File No.: 001-35803 | Film No.: 24768636
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)